Mike Polini

Precision Medicine, Custom Cures

Margaret Anderson, Mike Polini, Jim Greenwood, George Church, Retta Berry, Chris Austin

Led by former NIH Director Francis Collins and moderated by Margaret Anderson, a diverse panel of scientists, industry leaders, and patient advocates examined the critical gap between rapid advances in precision medicine sequencing and clinical deployment. While the discussion highlighted success stories like the Berry family's transition from a diagnostic odyssey to effective treatment and the rising adoption of gene therapies, it also exposed systemic bottlenecks in rare disease therapeutics, reimbursement models, and data silos that prevent timely translation of genetic discoveries into cures. The group concluded that realizing the full potential of this medical revolution requires structural healthcare reform, robust data-sharing frameworks, and a shift toward participatory medicine where patients actively drive their own health outcomes.